Cargando…

Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease

To discover multifunctional agents for the treatment of Alzheimer's disease (AD), a new series of 1,2,3-triazole-chromenone derivatives were designed and synthesized based on the multi target-directed ligands approach. The in vitro biological activities included acetylcholinesterase (AChE) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Karimi Askarani, Hajar, Iraji, Aida, Rastegari, Arezoo, Abbas Bukhari, Syed Nasir, Firuzi, Omidreza, Akbarzadeh, Tahmineh, Saeedi, Mina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592376/
https://www.ncbi.nlm.nih.gov/pubmed/33134975
http://dx.doi.org/10.1186/s13065-020-00715-0
_version_ 1783601171813892096
author Karimi Askarani, Hajar
Iraji, Aida
Rastegari, Arezoo
Abbas Bukhari, Syed Nasir
Firuzi, Omidreza
Akbarzadeh, Tahmineh
Saeedi, Mina
author_facet Karimi Askarani, Hajar
Iraji, Aida
Rastegari, Arezoo
Abbas Bukhari, Syed Nasir
Firuzi, Omidreza
Akbarzadeh, Tahmineh
Saeedi, Mina
author_sort Karimi Askarani, Hajar
collection PubMed
description To discover multifunctional agents for the treatment of Alzheimer's disease (AD), a new series of 1,2,3-triazole-chromenone derivatives were designed and synthesized based on the multi target-directed ligands approach. The in vitro biological activities included acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition as well as anti-Aβ aggregation, neuroprotective effects, and metal-chelating properties. The results indicated a highly selective BuChE inhibitory activity with an IC(50) value of 21.71 μM for compound 10h as the most potent compound. Besides, compound 10h could inhibit self-induced Aβ(1–42) aggregation and AChE-induced Aβ aggregation with 32.6% and 29.4% inhibition values, respectively. The Lineweaver–Burk plot and molecular modeling study showed that compound 10h targeted both the catalytic active site (CAS) and peripheral anionic site (PAS) of BuChE. It should be noted that compound 10h was able to chelate biometals. Thus, the designed scaffold could be considered as multifunctional agents in AD drug discovery developments. [Image: see text]
format Online
Article
Text
id pubmed-7592376
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-75923762020-10-29 Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease Karimi Askarani, Hajar Iraji, Aida Rastegari, Arezoo Abbas Bukhari, Syed Nasir Firuzi, Omidreza Akbarzadeh, Tahmineh Saeedi, Mina BMC Chem Research Article To discover multifunctional agents for the treatment of Alzheimer's disease (AD), a new series of 1,2,3-triazole-chromenone derivatives were designed and synthesized based on the multi target-directed ligands approach. The in vitro biological activities included acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition as well as anti-Aβ aggregation, neuroprotective effects, and metal-chelating properties. The results indicated a highly selective BuChE inhibitory activity with an IC(50) value of 21.71 μM for compound 10h as the most potent compound. Besides, compound 10h could inhibit self-induced Aβ(1–42) aggregation and AChE-induced Aβ aggregation with 32.6% and 29.4% inhibition values, respectively. The Lineweaver–Burk plot and molecular modeling study showed that compound 10h targeted both the catalytic active site (CAS) and peripheral anionic site (PAS) of BuChE. It should be noted that compound 10h was able to chelate biometals. Thus, the designed scaffold could be considered as multifunctional agents in AD drug discovery developments. [Image: see text] Springer International Publishing 2020-10-27 /pmc/articles/PMC7592376/ /pubmed/33134975 http://dx.doi.org/10.1186/s13065-020-00715-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Karimi Askarani, Hajar
Iraji, Aida
Rastegari, Arezoo
Abbas Bukhari, Syed Nasir
Firuzi, Omidreza
Akbarzadeh, Tahmineh
Saeedi, Mina
Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease
title Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease
title_full Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease
title_fullStr Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease
title_full_unstemmed Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease
title_short Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease
title_sort design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in alzheimer's disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592376/
https://www.ncbi.nlm.nih.gov/pubmed/33134975
http://dx.doi.org/10.1186/s13065-020-00715-0
work_keys_str_mv AT karimiaskaranihajar designandsynthesisofmultitargetdirected123triazoledimethylaminoacryloylchromenonederivativeswithpotentialuseinalzheimersdisease
AT irajiaida designandsynthesisofmultitargetdirected123triazoledimethylaminoacryloylchromenonederivativeswithpotentialuseinalzheimersdisease
AT rastegariarezoo designandsynthesisofmultitargetdirected123triazoledimethylaminoacryloylchromenonederivativeswithpotentialuseinalzheimersdisease
AT abbasbukharisyednasir designandsynthesisofmultitargetdirected123triazoledimethylaminoacryloylchromenonederivativeswithpotentialuseinalzheimersdisease
AT firuziomidreza designandsynthesisofmultitargetdirected123triazoledimethylaminoacryloylchromenonederivativeswithpotentialuseinalzheimersdisease
AT akbarzadehtahmineh designandsynthesisofmultitargetdirected123triazoledimethylaminoacryloylchromenonederivativeswithpotentialuseinalzheimersdisease
AT saeedimina designandsynthesisofmultitargetdirected123triazoledimethylaminoacryloylchromenonederivativeswithpotentialuseinalzheimersdisease